Dr. Yolanda Rosi Helfrich, MD

Dr. Helfrich practices at University Hospital in Ann Arbor, Michigan.

Dr. Helfrich's NPI, 1003903873, was assigned on October 5, 2006. Dr. Helfrich graduated from University of Michigan Medical School in 2001. Dr. Helfrich holds Michigan license 4301077776.

Dr. Helfrich's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

Dr. Helfrich's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Helfrich is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dmand AI also links Dr. Helfrich to 1 more hospital, named with a free account. Dr. Helfrich's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Helfrich practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Helfrich's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Helfrich is licensed in Michigan.

CMS data shows 1,203 Medicare services from Dr. Helfrich across 11 procedure codes in 2024, for 354 Medicare patients. Medicare paid $33,816 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 354 Medicare patients who saw Dr. Helfrich in 2024. The largest group is 65 to 74, with 156 patients. 66% of them have high blood pressure, and 62% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Helfrich's median patient age at 67, with 59% women.

In 2024, Dr. Helfrich wrote 51 Medicare Part D claims for 18 patients. 76% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $347 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

Dr. Helfrich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 281 procedures of removal of skin lesions by Dr. Helfrich, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 33 papers to Dr. Helfrich, published from 2014 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Dermatology, Epidermis and Internship and Residency. Dr. Helfrich has published most often in JAAD Case Rep. Dr. Helfrich's most frequent co-authors are John J. Voorhees, MD, Lisa E. Maier, MD and Dana Lynn Sachs, MD.

Dmand AI links Dr. Helfrich to 1 clinical trial. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous. Open Payments lists research payments to Dr. Helfrich that name 1 trial.

CMS Open Payments shows 8 general payments to Dr. Helfrich from 1 drug or device company in 2016. Travel and lodging make up the largest share, 84% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $1,297. It also lists 2 research payments totaling $1,258 from 2016 to 2017, naming 1 clinical trial.

Dr. Helfrich graduated from University of Michigan Medical School in 2001.